T. Bouillet

775 total citations
31 papers, 562 citations indexed

About

T. Bouillet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, T. Bouillet has authored 31 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in T. Bouillet's work include Cancer survivorship and care (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Colorectal and Anal Carcinomas (5 papers). T. Bouillet is often cited by papers focused on Cancer survivorship and care (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Colorectal and Anal Carcinomas (5 papers). T. Bouillet collaborates with scholars based in France, Switzerland and Australia. T. Bouillet's co-authors include Laurent Zelek, Éléna Paillaud, Frédéric Pamoukdjian, Vincent Lévy, Michaël Soussan, Jean‐François Morère, G. Des Guetz, Kader Chouahnia, David C. Currow and Antonio Viganò and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Cancer.

In The Last Decade

T. Bouillet

28 papers receiving 553 citations

Peers

Countries citing papers authored by T. Bouillet

Since Specialization

Citations

This map shows the geographic impact of T. Bouillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Bouillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Bouillet more than expected).

Fields of papers citing papers by T. Bouillet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Bouillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Bouillet. The network helps show where T. Bouillet may publish in the future.

Co-authorship network of co-authors of T. Bouillet

This figure shows the co-authorship network connecting the top 25 collaborators of T. Bouillet. A scholar is included among the top collaborators of T. Bouillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Bouillet. T. Bouillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activité Physique Adaptée et cancer métastatique : quels besoins et quelles attentes ? 2022 ·Bulletin du Cancer ·T. Bouillet, Florence Joly, Mahasti Saghatchian, (unknown), (unknown), (unknown), I. Krakowski	2
2	Utilité et mécanismes de l’activité physique en oncologie 2021 ·T. Bouillet	0
3	STRUCTURED PSYCHOSOCIAL INTERVENTION FOR FRENCH PATIENTS WITH METASTATIC CANCER IS POSSIBLE IN REAL LIFE 2020 ·SHILAP Revista de lepidopterología ·(unknown), David Spiegel, Barbara L. Andersen, (unknown), (unknown), (unknown), Charles Saunders, (unknown), T. Bouillet, (unknown), (unknown), Jean‐Yves Blay	1
4	Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review 2017 ·Clinical Nutrition ·Frédéric Pamoukdjian, T. Bouillet, Vincent Lévy, Michaël Soussan, Laurent Zelek, Éléna Paillaud	291
5	A Practical Approach to Fatigue Management in Colorectal Cancer 2016 ·Clinical Colorectal Cancer ·Matti Aapro, Florian Scotté, T. Bouillet, David C. Currow, Antonio Viganò	42
6	Role of physical activity and sport in oncology 2015 ·Critical Reviews in Oncology/Hematology ·T. Bouillet, (unknown), (unknown), (unknown), (unknown), S. Dauchy, Corinne Delcambre, (unknown), Florence Joly, (unknown), (unknown), F. Scotté, Jean-Philippe Spano, Laurence Vanlemmens, Laurent Zelek	51
7	Néphropathie post-radique 2012 ·Bulletin du Cancer ·T. Bouillet, (unknown), Juliette Thariat	5
8	Bénéfices sur la survie de l’activité physique avant ou après un cancer du sein 2011 ·ONCOLOGIE ·(unknown), T. Bouillet, P. Calmels, S. Dauchy, (unknown), Michel Pavic, F. Scotté, D. Serin	2
9	Apport de l’exercise physique en pratique cancérologique: soins de support, traitement, prophylaxie? 2008 ·ONCOLOGIE ·T. Bouillet	2
10	Traitement non chirurgical des rectites radiques chroniques hémorragiques 2008 ·La Presse Médicale ·Vincent de Parades, Pierre Bauër, Philippe Marteau, L. Chauveinc, T. Bouillet, Patrick Atienza	3
11	Traitement non chirurgical des rectites radiques chroniques hémorragiques 2007 ·Gastroentérologie Clinique et Biologique ·Vincent de Parades, Pierre Bauër, Philippe Marteau, L. Chauveinc, T. Bouillet, Patrick Atienza	5
12	Bilan préthérapeutique initial du carcinome épidermoïde invasif de l’anus 2007 ·Gastroentérologie Clinique et Biologique ·Vincent de Parades, Pierre Bauër, (unknown), T. Bouillet, Paul Cottu, C.A. Cuénod, C. Durdux, Jean–François Fléjou, Patrick Atienza	1
13	A randomized phase II study of concomitant CT (docetaxel±cisplatin) and (RT) in first-line treatment of locally advanced head and neck cancer (LAHNC) 2007 ·Journal of Clinical Oncology ·T. Bouillet, (unknown), Ayman Zawadi, Dominique Herman, Didier Cupissol, (unknown), (unknown), J Crétin, Jean‐François Morère	1
14	Métastase splénique d’un carcinome du sinus piriforme 2004 ·Journal de Chirurgie ·Kader Chouahnia, G. Des Guetz, T. Bouillet, (unknown), (unknown)	1
15	Phase II Study of Paclitaxel Combined With Vinorelbine in Patients With Advanced Breast Cancer 2004 ·American Journal of Clinical Oncology ·(unknown), T. Bouillet, C Boaziz, Sophie Piperno‐Neumann, P. Brunel, (unknown), (unknown), (unknown), (unknown), Franck Morin, (unknown), Jean‐François Morère	6
16	Weekly paclitaxel (P) combined with biweekly vinorelbine (V) in metastatic breast cancer (MBC): Final results of a clinical phase II study 2004 ·Journal of Clinical Oncology ·T. Bouillet, Pierre Saintigny, E. Lévy, Jean‐Philippe Spano, Françoise Morin, (unknown), Bernard Brun, (unknown), (unknown), Jean‐François Morère	5
17	Phase II study of paclitaxel (P) twice a week as a radiosensitizer, after paclitaxel-carboplatin (C) induction chemotherapy (IC) in stage IIId–IV head and neck carcinoma (HNC) 1999 ·European Journal of Cancer ·T. Bouillet, Jean‐François Morère, (unknown), Dominique Herman, (unknown), (unknown), (unknown), (unknown), P. Brunel, J.L. Breau	2
18	Vinorelbine and ifosfamide for unresectable non-small cell lung cancer 1997 ·Lung Cancer ·Jean‐François Morère, Sophie Piperno‐Neumann, (unknown), C Boaziz, (unknown), T. Bouillet, J.L. Breau	4
19	Chimiothérapie d'induction suivie d'une association concomitante de radiothérapie et de chimiothérapie pour les carcinomes bronchiques non à petites cellules de stade III 1997 ·Cancer/Radiothérapie ·T. Bouillet, Jean‐François Morère, Jean‐Jacques Mazeron, (unknown), C Boaziz, E. Haddad, (unknown)	3
20	[Treatment of advanced kidney cancer using recombinant erythropoietin]. 1997 ·PubMed ·Jean‐François Morère, T. Bouillet, Sophie Piperno‐Neumann, J.M. Tourani, (unknown), (unknown), (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact